ICON Public Limited Company Cash Conversion Cycle 2011-2026 | ICLR

Annual Cash Conversion Cycle ICON Public Limited Company

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	62	74.2	58.1	53.1	78.5	142	145	132	129	137	132

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
145	53.1	104

Quarterly Cash Conversion Cycle ICON Public Limited Company

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	60.2	-	45.9	63.8	66.2	-	58.3	67.7	63.2	-	50.2	51.9	53.2	-	54.2	56.8	56.9	-	69.4	70.2	76.3	-	81.6	78.8	85.7	-	83.9	82.4	85.1	-	85.6	83.9	86.8	-	85	73.4	76	-	69.1	66.3	69.4	-	66.6	66.4	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
86.8	45.9	69.4

Cash Conversion Cycle of other stocks in the Diagnostics research industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Anixa Biosciences ANIX	275	$ 2.96	4.59 %	$ 96.1 K	USA
Agilent Technologies A	111	$ 120.24	1.01 %	$ 36.6 B	USA
Centogene N.V. CNTG	50.2	-	-6.23 %	$ 30.6 M	Germany
Aspira Women's Health AWH	-38.7	-	-6.19 %	$ 10.5 M	USA
Burning Rock Biotech Limited BNR	149	$ 22.65	-3.78 %	$ 237 M	China
Castle Biosciences CSTL	45.9	$ 28.41	3.05 %	$ 789 M	USA
Akumin AKU	36.1	-	-17.87 %	$ 25.9 M	Canada
Fulgent Genetics FLGT	42.4	$ 14.16	2.68 %	$ 428 M	USA
Heska Corporation HSKA	138	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	104	-	-20.0 %	$ 1.06 M	USA
Charles River Laboratories International CRL	65	$ 179.46	2.15 %	$ 8.89 B	USA
Accelerate Diagnostics AXDX	364	-	-61.36 %	$ 2.46 M	USA
IDEXX Laboratories IDXX	103	$ 647.88	1.94 %	$ 52.1 B	USA
Illumina ILMN	142	$ 130.02	0.36 %	$ 20.7 B	USA
Global Cord Blood Corporation CO	184	-	-	$ 399 M	China
Genetic Technologies Limited GENE	11 K	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	142	-	0.12 %	$ 80.1 M	China
Laboratory Corporation of America Holdings LH	40.3	$ 281.34	-0.61 %	$ 23.4 B	USA
Lantheus Holdings LNTH	97.3	$ 78.17	-0.86 %	$ 5.28 B	USA
PRA Health Sciences, Inc. PRAH	1.21 K	-	-	$ 10.7 B	USA
Motus GI Holdings MOTS	3.45 K	-	-34.28 %	$ 263 K	Israel
Biodesix BDSX	41.7	$ 15.13	-2.4 %	$ 1.96 B	USA
Mettler-Toledo International MTD	66.4	$ 1 299.93	-1.22 %	$ 26.8 B	Schweiz
Biocept BIOC	78.1	-	-13.05 %	$ 7.29 M	USA
Myriad Genetics MYGN	49.3	$ 5.36	1.32 %	$ 496 M	USA
NeoGenomics NEO	82.4	$ 9.27	-2.83 %	$ 1.19 B	USA
Invitae Corporation NVTA	299	-	-	$ 21.2 M	USA
BioNano Genomics BNGO	225	$ 1.15	2.23 %	$ 1.46 M	USA
National Research Corporation NRC	33	$ 13.2	-1.46 %	$ 324 M	USA
Quest Diagnostics Incorporated DGX	39.5	$ 208.35	-	$ 23.1 B	USA
Danaher Corporation DHR	77.5	$ 205.14	0.54 %	$ 146 B	USA
Organovo Holdings ONVO	-82.8 K	-	-2.3 %	$ 19.4 M	USA
Exact Sciences Corporation EXAS	42.5	$ 103.51	0.13 %	$ 19.5 B	USA
OPKO Health OPK	242	$ 1.2	0.84 %	$ 833 M	USA
Bioventus BVS	208	$ 8.57	-1.95 %	$ 537 M	USA
Pacific Biosciences of California PACB	185	$ 1.59	4.28 %	$ 477 M	USA
DarioHealth Corp. DRIO	207	$ 9.51	-7.67 %	$ 270 M	Israel
DexCom DXCM	134	$ 73.14	0.08 %	$ 28.5 B	USA
PerkinElmer PKI	92.2	-	-0.91 %	$ 14.7 B	USA
Psychemedics Corporation PMD	45.3	-	-1.84 %	$ 15.3 M	USA
Precipio PRPO	-3.19	$ 26.97	7.99 %	$ 35 M	USA
QIAGEN N.V. QGEN	122	-	-	$ 10.6 B	Niderland
Personalis PSNL	-11.5	$ 8.84	1.96 %	$ 524 M	USA
Quotient Limited QTNT	345	-	-11.32 %	$ 1.1 M	Schweiz
Renalytix AI plc RNLX	15.9	-	5.66 %	$ 22.7 M	Britain
CareDx, Inc CDNA	51.5	$ 19.3	2.66 %	$ 1.03 B	USA